Insider · CIK 0001862192
Laurence Marton
director
Files at RNXT (RenovoRx, Inc.). First filing Apr 9, 2025, latest Apr 9, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$10k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNXT: RenovoRx, Inc.
RNXTOct 9, 2026 · close 1.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | RenovoRx, Inc. | $10k 12,050 shares | +36% | +1% from low-48% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | RNXT RenovoRx, Inc. | AGrant or award Stock Options (right to buy)derivative | +55,924 | $0.00 | $0 | 55,924 | 10 d ago |
| Mar 20, 2026 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stockindirect: Laurence Marton Rollover IRA | +9,720 | - | - | 9,720 | Mar 24, 2026 |
| Mar 20, 2026 | RNXT RenovoRx, Inc. | POpen-market purchase Warrantsderivativeindirect: Laurence Marton Rollover IRA | +4,860 | - | - | 4,860 | Mar 24, 2026 |
| Oct 1, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Options (right to buy)derivative | +47,640 | $0.00 | $0 | 47,640 | Oct 3, 2025 |
| May 2, 2025 | RNXT RenovoRx, Inc. | MOption exercise Common Stock | +20,480 | $0.15 | $3,072 | 66,164 | May 6, 2025 |
| May 2, 2025 | RNXT RenovoRx, Inc. | MOption exercise Stock Option (right to buy)derivative | -20,480 | $0.00 | $0 | 0 | May 6, 2025 |
| Apr 8, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +12,050 | $0.85 | $10k | 45,684 | Apr 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.